JOINT FILING AGREEMENT
Exhibit 99.2
The undersigned hereby agree that they are filing this statement jointly pursuant to Rule 13d-1(k)(1). Each of them is responsible for the timely filing of such Schedule 13D and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate.
In accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with each other on behalf of each of them of such a statement on Schedule 13D (and any amendments thereto) with respect to the Ordinary Shares, par value NIS 0.07 per share, beneficially owned by each of them, of MediWound Ltd., an Israeli corporation. This Joint Filing Agreement shall be included as an exhibit to such Schedule 13D.
Dated: February 13, 2023
| ACCESS INDUSTRIES HOLDINGS LLC | By: Access Industries Management, LLC, its Manager | |
| /s/ Xxxxxxxxx Xxxxxx | ||
| Name: Xxxxxxxxx Xxxxxx | ||
| Title: Executive Vice President | ||
| ACCESS INDUSTRIES MANAGEMENT, LLC | /s/ Xxxxxxxxx Xxxxxx | |
| Name: Xxxxxxxxx Xxxxxx | ||
| Title: Executive Vice President | ||
| ACCESS INDUSTRIES, LLC | By: Access Industries Management, LLC, its Manager | |
| /s/ Xxxxxxxxx Xxxxxx | ||
| Name: Xxxxxxxxx Xxxxxx | ||
| Title: Executive Vice President | ||
| CLAL INDUSTRIES LTD. | /s/ Xxxx Xxxxxx | |
| Name: Xxxx Xxxxxx | ||
| Title: VP Finance | ||
| /s/ Nufar Malovani | ||
| Name: Xxxxx Xxxxxxxx | ||
| Title: VP General Counsel & Corporate Secretary | ||
14
| CLAL BIOTECHNOLOGY INDUSTRIES LTD. | /s/ Xxxxx Xxxxx | |||||
| Name: Xxxxx Xxxxx | ||||||
| Title: CEO | ||||||
| /s/ Liat Nissan | ||||||
| Name: Liat Nissan | ||||||
| Title: VP Finance | ||||||
| CLAL LIFE SCIENCES L.P. | /s/ Xxxxx Xxxxx | |||||
| Name: Xxxxx Xxxxx | ||||||
| Title: Director | ||||||
| /s/ Liat Nissan | ||||||
| Name: Liat Nissan | ||||||
| Title: Director | ||||||
| * | ||||||
| Name: Xxx Xxxxxxxxx | ||||||
| * The undersigned, by signing his name hereto, executes this Schedule 13D pursuant to the Power of Attorney executed on behalf of Xx. Xxxxxxxxx and filed herewith. | ||||||
| By: | /s/ Xxxxxxxxx Xxxxxx | |||||
| Name: Xxxxxxxxx Xxxxxx | ||||||
| Title: Attorney-in-Fact | ||||||
15
Annex A
Directors and Officers of Clal Biotechnology Industries Ltd.
| Name |
Principal Business/Occupation |
Citizenship | ||
| Xxxxx Xxxxx | Chief Executive Officer of CBI | Israel | ||
| Liat Nissan | VP Finance | Israel | ||
| Xxx Xxxxxxx | Chairman of CBI; Chairman and Chief Executive Officer of Clal Industries Ltd., the controlling shareholder of CBI; Chairman of Claltech Investments (2016) LP; Chairman of Mashav Initiating and Development Ltd.; Chairman of Nesher Ltd.; Chairman of Clal Sun Ltd. | Israel | ||
| Xxxxx Xxxxx | Consulting and accompanying medical firms at Xxxxx Xxxxx Consulting and Management Ltd. | Israel | ||
| Xxxx. Xxxx Xxxxxxx | Chairman of Nara Medical Center Ltd.; Chief Executive of Consilium Israel; Director, Bench to Bedside program, Weizmann Institute of Science, Israel | Israel | ||
| Xxxx. Xxx Xxxxx | Professor of Cardiology, Sackler School of Medicine, Tel Aviv University; Head of Cardiology department, Assuta | Israel | ||
| Xxxxxxx Xxxxxxx | Business consultant | Israel | ||
| Xxxxx Xxxxxxxx | Vice President, General Counsel, Corporate Secretary and Human Resources Manager at Clal Industries Ltd. | Xxxxxx | ||
| Xxxxx Xxxxx | Senior analyst at Clal Industries Ltd.; Vice President of Claltech Investments (2016) LP. | Israel | ||
The address for each director and officer is c/o Clal Biotechnology Industries Ltd., 3 Azrieli Center Triangle Tower, 45 Floor, 132 Xxxxxxxx Xxxxx Xx. Xxx Xxxx 0000000, Xxxxxx.
16
